World News Insights
1-3 Minute Gist

All Topics Article

Takeda in Talks to Acquire Nycomed

Wall Street Journal Original article ›

Keywords:

LyrArc Article Gist
Takeda Pharmaceutical is negotiating the acquisition of Swiss drugmaker Nycomed for about $14 billion. Takeda has cash reserves of $10.8 billion and will be using this to fund the acquisition, as well as loans from banks. The strong yen has made acquisitions easier for Japanese companies. Takeda's Prevacid ulcer treatment and the Actos diabetes treatment have both expired. A generic launch of Actos is expected in August 2011. Takeda bought the U.S. unit of Millenium Pharmaceutical in 2008 for $8.9 billion for a significant presence in the oncology field. Takeda projects a drop in net profit by April 2013 by 35%, and sales by 11%, for the fiscal year 2013. Takeda's president says it will make investments in China of about 20-30 billon yen and target a ten fold increase in sales in China to 30 billion yen by 2015.

Takeda Pharmaceutical performance

02/05/2008

Grouped Articles

Amgen Gets a Lift in Deal With Takeda

Wall Street Journal 02/05/2008

Takeda Move Marks Shift for Japan Inc.

Wall Street Journal 04/03/2014

Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos

New York Times 04/28/2015

Takeda to Pay Billions to Get Into Biotech

Wall Street Journal 04/11/2008

Takeda's President Places Bet On U.S. Biotechnology Firms

Wall Street Journal 05/28/2008

Takeda Annual Net Fell 34%

Wall Street Journal 05/12/2009


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us